63 related articles for article (PubMed ID: 665117)
1. The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases.
Piccinino F; Manzillo G; Sagnelli E; Balestrieri GG; Maio G; Pasquale G; Felaco FM
Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):171-8. PubMed ID: 665117
[TBL] [Abstract][Full Text] [Related]
2. Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier state.
Feinman SV; Cooter N; Sinclair JC; Wobel DM; Berris B
Gastroenterology; 1975 Jan; 68(1):113-20. PubMed ID: 1116653
[TBL] [Abstract][Full Text] [Related]
3. A histological and serological study of persistent hepatitis B antigenaemia.
Pinn TG; Woodfield DG
N Z Med J; 1983 Mar; 96(727):153-6. PubMed ID: 6572313
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
Koçak N; Ozen H; Yüce A; Gürakan F
Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
[TBL] [Abstract][Full Text] [Related]
5. Histological, biochemical and clinical findings in hepatitis B carriers undergoing elective abdominal surgery.
Pramoolsinsap C; Kurathong S; Bunyaratvej S
Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):571-8. PubMed ID: 3238467
[TBL] [Abstract][Full Text] [Related]
6. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection in allogeneic bone marrow transplantation.
Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and natural history of chronic persistent hepatitis. A multicentre retrospective study on 1197 cases.
Giusti G; Galanti B; Gaeta GB; Sagnelli E; Piccinino F; Ruggiero G
Ital J Gastroenterol; 1991; 23(3):111-8. PubMed ID: 1742503
[TBL] [Abstract][Full Text] [Related]
9. [2-year follow-up of a series of cases of asymptomatic carriers of HBsAg antigen].
Menicagli V
Arch Sci Med (Torino); 1982; 139(1):99-104. PubMed ID: 7103714
[TBL] [Abstract][Full Text] [Related]
10. Liver histology in 34 "HPsAg long-term healthy carriers.
Piccinino F; Sagnelli E; Manzillo G; Pasquale G
Acta Hepatogastroenterol (Stuttg); 1977 Jun; 24(3):148-54. PubMed ID: 883462
[TBL] [Abstract][Full Text] [Related]
11. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
[TBL] [Abstract][Full Text] [Related]
12. [Role of chronic HBsAg carriers in intrafamilial diffusion of hepatitis B virus infection].
Pastore G; Dentico P; Angarano G; Pesce V; Schiraldi O
Boll Ist Sieroter Milan; 1978 May; 57(2):197-203. PubMed ID: 728268
[TBL] [Abstract][Full Text] [Related]
13. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.
Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM
Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885
[TBL] [Abstract][Full Text] [Related]
14. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
[TBL] [Abstract][Full Text] [Related]
15. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
[TBL] [Abstract][Full Text] [Related]
16. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR
Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
[TBL] [Abstract][Full Text] [Related]
17. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
Chang MH; Hsu HY; Hsu HC; Ni YH; Chen JS; Chen DS
Hepatology; 1995 Nov; 22(5):1387-92. PubMed ID: 7590652
[TBL] [Abstract][Full Text] [Related]
18. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
[TBL] [Abstract][Full Text] [Related]
20. The etiology of chronic active hepatitis in Korea.
Prince AM; Gershon RK
Yale J Biol Med; 1979; 52(2):159-67. PubMed ID: 377825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
